基于能值分析的中国海洋生态经济可持续发展评价

海洋生态经济可持续发展的研究既是生态经济研究的重要领域,也是海洋经济研究的重点领域。运用能值分析构建中国海洋生态经济系统能值分析模型和指标体系,以中国沿海地区及其附近海域为研究区域,利用2013年的数据对中国海洋生态经济系统的可持续发展水平进行能值测度。研究表明:(1)2013年,中国沿海各省的海洋生态经济总能值为1.70×10~(24)sej,可更新资源能值占主体地位。(2)受沿海各省海洋经济发展水平不同和区域海洋资源储量影响,中国沿海地区海洋生态经济能值密度分布差异较大,能值货币比率以上海为界,南高北低,高中低3种能值产出率结构并存且以中能值产出率结构为主。(3)中国海洋生态经济系统的生态承载力以高承载力和较高承载力为主,但局部地区海洋生态承载力偏低影响区域海洋生态系统平衡。中国海洋生态经济系统环境负载率较大,环境负载率高的地区与我国海洋经济发达地区高度耦合。(4)从可持续发展指数来看,中国海洋生态经济发展的整体可持续性较好,局部地区环境负载率过大和生态承载力偏低严重制约着区域海洋生态经济的可持续发展。     

海洋产业生态化关键因素识别

科学合理地识别海洋产业生态化的关键因素,判明各指标间相互影响程度和因果关系,对于现阶段海洋产业生态化转型至关重要.本研究以海洋产业生态化概念模型的提出为基础,从海洋产业结构生态化、海洋产业组织生态化、海洋产业生产方式生态化和海洋产业技术创新生态化4个方面构建区域海洋产业生态化的影响因素评价体系,应用DEMATEL方法分析各影响因素之间的关系,并绘制影响网络关系图.结果表明: 海洋产业生产方式生态化与海洋产业技术创新生态化处于评价的核心位置,是整个生态化水平评估维度的起因,影响着海洋产业组织生态化和海洋产业结构生态化.最后结合各个维度的具体指标,提出了改进和完善海洋产业生态化转型的相关对策和建议.     

海洋古菌多样性研究进展

海洋古菌是海洋微生物中的一个大的类群,然而绝大多数的古菌不能分离培养.近年来分子生物学的方法广泛地应用于微生物多样性的研究中,研究发现,海洋古菌广泛地生活在各类海域环境中,而不仅仅是生活在极端的环境中.海洋古菌为海洋生态系统中主要的原核细胞成分,在海洋生态系统中的物质与能量循环中扮演着重要角色.主要阐述了生活在海洋不同环境中海洋古菌的多样性,有海洋浮游古菌的多样性、海底环境及海洋沉积物中古菌的多样性、附着或寄共生古菌多样性等的研究状况,以及研究海洋古菌多样性的分子生物学的主要方法.     

Proposal of a marine protected area surveillance system against illegal vessels using image sensing and image processing

Conservation of marine fauna is a great concern in the present days for a number of reasons. Implementation of marine protected area is considered to be a common practice for the conservation of marine fauna at a specific area. However, in many cases, the present management system of the marine protected areas fails to protect marine fauna. This paper proposes a marine protected area surveillance system that uses airborne image sensing and digital image processing to monitor the marine protected area against illegal vessels efficiently. The system architecture, including the system structure, execution planning, and algorithm, has been described for the proposed surveillance system. It is apparent from this study that the currently proposed marine protected area surveillance system is better than the previously proposed ones.     

黄海海域海洋沉积物细菌多样性分析

【背景】海洋独特的环境造就了海洋生物的多样性,海洋沉积物中细菌对海洋环境具有至关重要的作用。【目的】研究陆地土壤和海洋沉积物间细菌群落相似性和差异性,以便更好地认识海洋细菌多样性,深入了解沉积物细菌在海洋环境中的潜在作用。【方法】从中国黄海海域及大连市大黑山脚下分别采集样品,以陆地土壤为对照,采用16SrRNA基因高通量测序技术分析海洋沉积物的细菌群落结构。【结果】海洋沉积物样品中芽孢杆菌纲(Bacilli)、鞘氨醇单胞菌属(Sphingomonas)和芽孢杆菌属(Bacillus)丰度高于陆地土壤样品;海洋沉积物中亚硝化单胞菌(unculturedbacterium f. Nitrosomonadaceae)和厌氧绳菌(uncultured bacterium f. Anaerolineaceae)丰度虽低于陆地土壤,但丰度值也均高于1%;样品分类学统计显示酸杆菌门(Acidobacteria)在海洋沉积物和陆地土壤样品中的序列丰度比例都较大,鞘氨醇单胞菌属(Sphingomonas)在海洋沉积物样品中的序列丰度大于陆地土壤样品。【结论】海洋沉积物细菌多样性可作为海洋环境恢复情况的重要指标,研究为合理开发和利用海洋资源提供理论依据。     

“海洋生态系统工程师”及其生态作用

“海洋生态系统工程师”是能够塑造栖息地并使其他海洋生物受益的海洋生物种类。海洋中的植物、动物和微生物中均存在为其他生物种类塑造栖息地的“海洋生态系统工程师”,它们的生态作用是其发挥生态功能的基础。本文基于国内外相关文献,系统阐述了“海洋生态系统工程师”生态作用的相关研究进展,并对今后的主要研究方向和内容提出建议。“海洋生态系统工程师”能够在特定的海洋环境中发挥积极作用,但一旦成为入侵种可能会对入侵海域产生负面影响;有些“海洋生态系统工程师”在发挥积极作用的同时也会在不同程度上带来负面影响。今后,应加强海洋生物床、海洋生物礁、海洋生物膜和复合生态系统工程等研究,有效利用“海洋生态系统工程师”的积极作用并防控其负面影响,实现对海洋的综合开发利用和保护。     

小尺度海域空间评价单元划分技术研究——以福建省东山湾为例

科学合理的海域空间评价单元划分是各类海洋空间监测、评价、规划和管理的基础工作,对于保护海洋生态环境,实现海洋资源的可持续开发利用具有重大现实意义。然而,海洋的流动性、开放性、边界模糊性等特征,导致海洋空间评价单元划分较陆地而言更为复杂、困难。以福建省东山湾为例,提出一种适用于小尺度海域的空间评价单元划分技术方案,通过从化学属性、物理属性、生物学属性三个方面构建海域空间生态属性划分指标体系,进行空间分类评价,运用插值、叠加分析等GIS技术将东山湾划分为67个基本空间评价单元。研究结果不仅能为进一步划定东山湾海洋空间规划提供技术支持,同时为其他小尺度海域生态监测、评价、规划和管理提供科学参考。     

Marine pharmacology in 2007–8: Marine compounds with antibacterial,anticoagulant, antifungal,anti-inflammatory,antimalarial, antiprotozoal,antituberculosis, and antiviral activities; affecting the immune and nervous system,and other miscellaneous mechanisms of action

The peer-reviewed marine pharmacology literature in 2007–8 is covered in this review, which follows a similar format to the previous 1998–2006 reviews of this series. The preclinical pharmacology of structurally characterized marine compounds isolated from marine animals, algae, fungi and bacteria is discussed in a comprehensive manner. Antibacterial, anticoagulant, antifungal, antimalarial, antiprotozoal, antituberculosis and antiviral activities were reported for 74 marine natural products. Additionally, 59 marine compounds were reported to affect the cardiovascular, immune and nervous systems as well as to possess anti-inflammatory effects. Finally, 65 marine metabolites were shown to bind to a variety of receptors and miscellaneous molecular targets, and thus upon further completion of mechanism of action studies, will contribute to several pharmacological classes. Marine pharmacology research during 2007–8 remained a global enterprise, with researchers from 26 countries, and the United States, contributing to the preclinical pharmacology of 197 marine compounds which are part of the preclinical marine pharmaceuticals pipeline. Sustained preclinical research with marine natural products demonstrating novel pharmacological activities, will probably result in the expansion of the current marine pharmaceutical clinical pipeline, which currently consists of 13 marine natural products, analogs or derivatives targeting a limited number of disease categories.     

海洋微塑料污染的生态效应研究进展

海洋微塑料污染已成为全球性环境问题。微塑料粒径小,易与海洋生物发生相互作用,可通过多种途径进入海洋生物体内,并在其组织和器官中蓄积和转移,对机体产生毒害。微塑料可沿食物链进行传递,威胁海洋生态系统的健康与稳定。因此,海洋生物与微塑料的相互作用以及海洋微塑料污染的生态效应成为当前研究的热点。综述微塑料的生物附着、生物摄入、对海洋生物的毒性效应及其与化学污染物的复合毒性效应研究的基础上,提出未来微塑料生态效应研究应重点关注我国海洋环境中微塑料的污染现状及生物摄入状况、微塑料的生物效应及其毒理学机制研究、微塑料与其他污染物的复合效应、以及微塑料在海洋生态系统中的作用及其生物地球化学行为等。     

海洋可持续发展目标与海洋和滨海生态系统管理

海洋和海岸带可以为人类提供多种生态系统服务,保护与持续利用海洋资源以促进海洋和海岸带可持续发展已被正式纳入联合国可持续发展目标。实施海洋可持续发展目标面临几大挑战,包括如何减小陆基人类活动的影响、加强海岸带的综合管理、提高海洋资源效率、适应气候变化和提高沿海居民的人类福祉等。为应对这些挑战,需要将海洋和海岸带融合为一个大型生态系统,利用基于生态系统的管理方法,综合考虑各个部门和多种胁迫因素的累积影响,通过建立综合的海洋观测体系,合理划分海洋功能区,按照海洋环境承载力限制陆基人类活动,合理配置并有效利用海洋资源,提升海洋和海岸带生态系统的整体服务功能,从而进一步推进实施海洋可持续发展目标。     

Evaluation of dihydrooroidin as an antifouling additive in marine paint

Methods used to deter biofouling of underwater structures and marine vessels present a serious environmental issue and are both problematic and costly for government and commercial marine vessels worldwide. Current antifouling methods include compounds that are toxic to aquatic wildlife and marine ecosystems. Dihydrooroidin (DHO) was shown to completely inhibit Halomonas pacifica biofilms at 100 μM in a static biofilm inhibition assay giving precedence for the inhibition of other marine biofilm-forming organisms. Herein we present DHO as an effective paint-based, non-cytotoxic, antifouling agent against marine biofouling processes in a marine mesocosm.     

海洋生物资源与可持续利用对策研究

海洋生态环境恶化和不合理的开发利用,使我国海洋生物资源严重衰退。开展海洋生物资源学相关基础研究,重点进行海洋环境与生物资源保护,运用海洋生物技术等高新技术,科学、合理地开发利用生物资源,是实现海洋生物资源可持续利用和长久发展的可行策略。着重分析了海洋生物资源状况及其生态环境问题,提出了未来我国海洋生物资源的发展对策。     

Marine yeasts as biocontrol agents and producers of bio-products

As some species of marine yeasts can colonize intestine of marine animals, they can be used as probiotics. It has been reported that β-glucans from marine yeast cells can be utilized as immuno-stimulants in marine animals. Some siderophores or killer toxins produced by marine yeasts have ability to inhibit growth of pathogenic bacteria or kill pathogenic yeasts in marine animals. The virulent factors from marine pathogens can be genetically displayed on marine yeast cells, and the yeast cells displaying the virulent factors can stimulate marine animals to produce specific antibody against the pathogens. Some marine yeast cells are rich in proteins and essential amino acids and can be used in nutrition for marine animals. The marine yeast cells rich in lipid can be used for biodiesel production. Recently, it has been reported that some strains of Yarrowia lipolytica isolated from marine environments can produce nanoparticles. Because many marine yeasts can remove organic pollutants and heavy metals, they can be applied to remediation of marine environments. It has been shown that the enzymes produced by some marine yeasts have many unique properties and many potential applications.     

Major bioactive metabolites from marine fungi: A Review

Biologists and chemists of the world have been attracted towards marine natural products for the last five decades. Approximately 16,000 marine natural products have been isolated from marine organisms which have been reported in approximately 6,800 publications, proving marine microorganisms to be a invaluable source for the production of novel antibiotic, anti tumor, and anti inflammatory agents. The marine fungi particularly those associated with marine alga, sponge, invertebrates, and sediments appear to be a rich source for secondary metabolites, possessing Antibiotic, antiviral, antifungal and antiyeast activities. Besides, a few growth stimulant properties which may be useful in studies on wound healing, carcinogenic properties, and in the study of cancers are reported. Recent investigations on marine filamentous fungi looking for biologically active secondary metabolites indicate the tremendous potential of them as a source of new medicines. The present study reviews about some important bioactive metabolites reported from marine fungal strains which are anti bacterial, anti tumour and anti inflammatory in action. It highlights the chemistry and biological activity of the major bioactive alkaloids, polyketides, terpenoids, isoprenoid and non-isoprenoid compounds, quinones, isolated from marine fungi.     

用海建设项目海洋生态损失补偿评估方法及应用

海洋生态补偿是一种防止海洋生态破坏、增强和促进海洋生态系统良性发展的环境政策,是用海者履行海洋资源有偿使用责任,对因开发利用海洋资源造成的海洋生态价值损失进行的货币化补偿。基于快速化、定量化和差别化补偿评估原则,编制了山东近海海域生态价值基准值表、生态损害系数表以及补偿系数表,建立了一种新的用海建设项目海洋生态损失补偿评估方法体系,包括占用海域和邻近影响海域的海洋生物资源和海洋生态系统服务两个方面的海洋生态价值损失补偿评估。针对2016年山东省5个典型用海项目,核算了其需要缴纳的海洋生态补偿资金,并与旧标准《山东省海洋生态损害赔偿和损失补偿评估方法》(DB37/T 1448—2009)的评估结果进行了对比。结果表明,按照本评估方法,用海企业需要缴纳的生态补偿资金会不同程度地提高,这将有利于用海企业增强资源有偿使用意识,引导企业理性用海,市场经济条件下这有利于海洋资源的优化配置,提高用海效率;另外,按照产业政策不同、受影响海域的生态脆弱性不同对用海建设项目造成的海洋生态损失进行差别化补偿,使得海洋生态补偿标准的评估结果更加科学合理。目前,该方法已经应用于山东海域7个沿海地市9个海区的海洋生态损失补偿评估中,被新发布的山东省地方标准《用海建设项目海洋生态损失补偿评估技术导则》(DB37/T 1448—2015)吸收采用。该评估方法可为海洋管理部门的生态资本核算、生态补偿核算、环评审批和发放许可证提供科学基础,对我国海洋生态环境保护和海洋经济绿色发展以及生态补偿制度实施具有积极推动作用。     

Association of Marine Archaea with the Digestive Tracts of Two Marine Fish Species

Recent studies have shown that archaea which were always thought to live under strict anoxic or extreme environmental conditions are also present in cold, oxygenated seawater, soils, the digestive tract of a holothurian deep-sea-deposit feeder, and a marine sponge. In this study, we show, by using PCR-mediated screening in other marine eukaryotes, that marine archaea are also present in the digestive tracts of flounder and grey mullet, two fish species common in the North Sea, in fecal samples of flounder, and in suspended particulate matter of the North Sea water column. No marine archaea could be detected in the digestive tracts of mussels or the fecal pellets of a copepod species. The archaeal 16S ribosomal DNA clone libraries of feces of flounder and the contents of the digestive tracts of grey mullet and flounder were dominated by group II marine archaea. The marine archaeal clones derived from flounder and grey mullet digestive tracts and feces formed a distinct cluster within the group II marine archaea, with 76.7 to 89.8% similarity to previously described group II clones. Fingerprinting of the archaeal community of flounder digestive tract contents and feces by terminal restriction fragment length polymorphism of archaeal 16S rRNA genes after restriction with HhaI showed a dominant fragment at 249 bp, which is likely to be derived from group II marine archaea. Clones of marine archaea that were closely related to the fish-associated marine archaea clones were obtained from suspended particulate matter of the water column at two stations in the North Sea. Terminal restriction fragment length polymorphism fingerprinting of the archaeal community present in suspended particulate matter showed the same fragment pattern as was found for the archaeal community of the flounder digestive tract contents and feces. These data demonstrate that marine archaea are present in the digestive tracts and feces of very common marine fish. It is possible that the marine archaea associated with the digestive tracts of marine fish are liberated into the water column through the feces and subsequently contribute to the marine archaeal community of suspended particulate matter.     

Marine Mammal Impacts in Exploited Ecosystems: Would Large Scale Culling Benefit Fisheries?

Competition between marine mammals and fisheries for marine resources-whether real or perceived-has become a major issue for several countries and in international fora. We examined trophic interactions between marine mammals and fisheries based on a resource overlap index, using seven Ecopath models including marine mammal groups. On a global scale, most food consumed by marine mammals consisted of prey types that were not the main target of fisheries. For each ecosystem, the primary production required (PPR) to sustain marine mammals was less than half the PPR to sustain fisheries catches. We also developed an index representing the mean trophic level of marine mammal's consumption (TL(Q)) and compared it with the mean trophic level of fisheries' catches (TL(C)). Our results showed that overall TL(Q) was lower than TL(C) (2.88 versus 3.42). As fisheries increasingly exploit lower-trophic level species, the competition with marine mammals may become more important. We used mixed trophic impact analysis to evaluate indirect trophic effects of marine mammals, and in some cases found beneficial effects on some prey. Finally, we assessed the change in the trophic structure of an ecosystem after a simulated extirpation of marine mammal populations. We found that this lead to alterations in the structure of the ecosystems, and that there was no clear and direct relationship between marine mammals' predation and the potential catch by fisheries. Indeed, total biomass, with no marine mammals in the ecosystem, generally remained surprisingly similar, or even decreased for some species.     

Discovery of novel metabolites from marine actinomycetes

Recent findings from culture-dependent and culture-independent methods have demonstrated that indigenous marine actinomycetes exist in the oceans and are widely distributed in different marine ecosystems. There is tremendous diversity and novelty among the marine actinomycetes present in marine environments. Progress has been made to isolate novel actinomycetes from samples collected at different marine environments and habitats. These marine actinomycetes produce different types of new secondary metabolites. Many of these metabolites possess biological activities and have the potential to be developed as therapeutic agents. Marine actinomycetes are a prolific but underexploited source for the discovery of novel secondary metabolites.     

A triage framework for managing novel,hybrid, and designed marine ecosystems

The novel ecosystem (NE) concept has been discussed in terrestrial restoration ecology over the last 15 years but has not yet found much traction in the marine context. Against a background of unprecedented environmental change, managers of natural marine resources have portfolios full of altered systems for which restoration to a previous historical baseline may be impractical for ecological, social, or financial reasons. In these cases, the NE concept is useful for weighing options and emphasizes the risk of doing nothing by forcing questions regarding the value of novelty and how it can best be managed in the marine realm. Here, we explore how the concept fits marine ecosystems. We propose a scheme regarding how the NE concept could be used as a triage framework for use in marine environments within the context of a decision framework that explicitly considers changed ecosystems and whether restoration is the best or only option. We propose a conceptual diagram to show where marine NEs fit in the continuum of unaltered to shifted marine ecosystems. Overall, we suggest that the NE concept is of interest to marine ecologists and resource managers because it introduces a new vocabulary for considering marine systems that have been changed through human actions but have not shifted to an alternate stable state. Although it remains to be seen whether the concept of marine NEs leads to better conservation and restoration decisions, we posit that the concept may help inform management decisions in an era of unprecedented global marine change.     

Bio-mining the microbial treasures of the ocean: new natural products

The biological resources of the oceans have been exploited since ancient human history, mainly by catching fish and harvesting algae. Research on natural products with special emphasis on marine animals and also algae during the last decades of the 20th century has revealed the importance of marine organisms as producers of substances useful for the treatment of human diseases. Though a large number of bioactive substances have been identified, some many years ago, only recently the first drugs from the oceans were approved. Quite astonishingly, the immense diversity of microbes in the marine environments and their almost untouched capacity to produce natural products and therefore the importance of microbes for marine biotechnology was realized on a broad basis by the scientific communities only recently. This has strengthened worldwide research activities dealing with the exploration of marine microorganisms for biotechnological applications, which comprise the production of bioactive compounds for pharmaceutical use, as well as the development of other valuable products, such as enzymes, nutraceuticals and cosmetics. While the focus in these fields was mainly on marine bacteria, also marine fungi now receive growing attention. Although culture-dependent studies continue to provide interesting new chemical structures with biological activities at a high rate and represent highly promising approaches for the search of new drugs, exploration and use of genomic and metagenomic resources are considered to further increase this potential. Many efforts are made for the sustainable exploration of marine microbial resources. Large culture collections specifically of marine bacteria and marine fungi are available. Compound libraries of marine natural products, even of highly purified substances, were established. The expectations into the commercial exploitation of marine microbial resources has given rise to numerous institutions worldwide, basic research facilities as well as companies. In Europe, recent activities have initiated a dynamic development in marine biotechnology, though concentrated efforts on marine natural product research are rare. One of these activities is represented by the Kieler Wirkstoff-Zentrum KiWiZ, which was founded in 2005 in Kiel (Germany).